Comprehensive Index of National Vaccine Injury Compensation Program Cases ← all cases Home Firms Attorneys Stats Special Masters About Us

Bekman, Marder, Hopper, Malarkey

Law Firm · Petitioner Practice VICP Petitioner Practice Last verified
Cases filed
1
Comp rate
100%
Total awarded
$90K
Tenure
2023
Heads up: The case docket, statistics, and overview below are compiled from AI-extracted data. Specific figures (case counts, awards, outcomes) may contain errors. Verify with the firm directly or with source court records before relying on them.
Bekman, Marder, Hopper, Malarkey is a U.S. law firm whose name appears on 1 petition in the National Vaccine Injury Compensation Program. The single recorded filing dates to 2023; compensation rate of 100%. Cases on file have produced $90K in total awards. The attorneys appearing on this firm's docket include Paul D. Bekman.
AI-generated overview · may contain errors. Verify details with the firm directly before relying on them.
Attorneys at this firm (by case volume)
Paul D. Bekman1
Most-handled condition categories
SIRVA (shoulder injury related to vaccine administration)1

Frequently asked questions about Bekman, Marder, Hopper, Malarkey

Answers built from this firm's public case docket.

How do I find a good VICP lawyer?
Most petitioners hire counsel because the program's evidentiary burden, expert-witness requirements, and procedural rules are complex. Reasonable attorney fees in VICP cases are paid by the program — not by the petitioner — under 42 U.S.C. § 300aa-15(e)(1), so engaging counsel does not reduce a successful petitioner's recovery. You can submit a free inquiry → to have your case forwarded to attorneys with VICP experience, or research Bekman, Marder, Hopper, Malarkey's case history below.
How many VICP cases has Bekman, Marder, Hopper, Malarkey filed?
Bekman, Marder, Hopper, Malarkey has filed 1 petitions in the U.S. Vaccine Injury Compensation Program with publicly-available decisions, between 2023 and 2023.
What is Bekman, Marder, Hopper, Malarkey's compensation rate?
Bekman, Marder, Hopper, Malarkey's overall compensation rate across 1 VICP cases is 100% (1 compensated).
How much has Bekman, Marder, Hopper, Malarkey won in VICP cases?
Cases filed by Bekman, Marder, Hopper, Malarkey have resulted in $90K in total compensation awards from the U.S. Vaccine Injury Compensation Program (visible-in-public-decisions only).
What kinds of vaccine injury cases does Bekman, Marder, Hopper, Malarkey handle?
Based on the cases on file, Bekman, Marder, Hopper, Malarkey's practice includes SIRVA (shoulder injury related to vaccine administration), among other vaccine-related conditions.
FiledFinal judgementPetitionerAttorneyFirm Age at VaccinationVaccineCondition OutcomeSpecial MasterAward
2021-07-222023-03-13James MeasePaul D. BekmanBekman, Marder, Hopper, Malarkey–influenzaShoulder Injury Related to Vaccine Administration (SIRVA)compensatedBrian H. Corcoran$89,547